课题基金 / 基金详情

Novel Imaging Biomarker for Treating Spatial Memory Loss in Prodromal Alzheimer's Disease Models

Novel Imaging Biomarker for Treating Spatial Memory Loss in Prodromal Alzheimer's Disease Models
用于治疗前驱阿尔茨海默病模型中空间记忆丧失的新型成像生物标志物
批准号:
9925773
负责人:
BRUCE A. BERKOWITZ
金额:
$55.87万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-09-15 至 2022-05-31

项目摘要

项目成果

BRUCE A. BERKOWITZ的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Project Summary / Abstract: There is an urgent need for disease-modifying treatment of Alzheimer's disease (AD) starting at its very onset. This knowledge gap remains because conventional approaches cannot measure in vivo brain region-specific biomarkers of the earliest relevant dysfunction underlying abnormal behavior. Often, spatial disorientation is observed during prodromal AD, and its occurrence predicts later dementia. A brain region contributing to this spatial confusion is the CA1 subfield of hippocampus because of its essential role in encoding spatial information. HC oxidative stress is most commonly identified at the very start of AD, and in experimental models of AD. Yet, it has not been possible to prove that prodromal oxidative stress in the relevant CA1 subfield plays a pathogenic role in at-risk patients showing impaired spatial memory because conventional methods only measure oxidative stress from post-mortem tissue. Addressing this major knowledge gap requires a new paradigm that compares antioxidant treatment efficacy in HC CA1 subregions in vivo with improved spatial learning and memory in experimental models, and that can then be translated into patients. In this proposal, we present a transformative solution to this problem based on a novel method recently discovered by our lab: QUEnch-assiSTed MRI (QUEST MRI). QUEST MRI is a robust and sensitive tool that has been validated against “gold standard” methods and maps in vivo excessive free radical production in, for example, murine dorsal CA1. The QUEST MRI index of abnormally high production of paramagnetic free radicals in specific brain regions is a greater- than-normal spin-lattice relaxation rate R1 (1/T1) that can be returned to baseline after acute antioxidant administration. Our QUEST MRI studies have confirmed dorsal HC CA1-specific oxidative stress in spontaneous and familial AD mouse models with declines in spatial learning and memory in conjunction with HC CA1 oxidative stress measured ex vivo. We also find downstream consequences of oxidative stress such as greater-than-normal amounts of the lipid peroxidation product 4-hydroxynonenal (HNE), dorsal HC CA1 calcium dysregulation and reductions in dorsal HC CA1 calcium-dependent afterhyperpolarization (AHP). To improve statistical power, this proposal is tightly focused on uniquely testing a specific working hypothesis that oxidative stress in dorsal CA1 in vivo causes deterioration of spatial memory in experimental models. Our highly innovative studies by an experienced team of experts will validate a new bridging tool for testing in vivo antioxidant therapeutic strategies to mitigate a clinically important early decline in spatial memory preceding later loss of personhood in AD.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Novel Early Retinal Imaging Biomarkers for Treating Later Spatial Memory Loss in Experimental Alzheimer's Disease
  • 批准号:
    10650636
  • 项目类别:
  • 资助金额:
    $113.56万
  • 财政年份:
    2023
  • 负责人:
    BRUCE A. BERKOWITZ
  • 依托单位:
Mitigating retinitis pigmentosa based on a non-invasive rod energy-landscape biomarker
  • 批准号:
    10733154
  • 项目类别:
  • 资助金额:
    $50.18万
  • 财政年份:
    2023
  • 负责人:
    BRUCE A. BERKOWITZ
  • 依托单位:
Novel Imaging Biomarker for Treating Spatial Memory Loss in Prodromal Alzheimer's Disease Models
  • 批准号:
    10165441
  • 项目类别:
  • 资助金额:
    $55.87万
  • 财政年份:
    2017
  • 负责人:
    BRUCE A. BERKOWITZ
  • 依托单位:
Role of calcium channels in the development of diabetic retinopathy
  • 批准号:
    8635018
  • 项目类别:
  • 资助金额:
    $19.0万
  • 财政年份:
    2014
  • 负责人:
    BRUCE A. BERKOWITZ
  • 依托单位:
海外基金